ProShares Trust II

For the period ended Dec 31, 2024. Filed Feb 28, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 28, 2025

SCO$20.19+2.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

ProShares Ultra Euro

	December 31, 2024	December 31, 2023
Assets
Cash	$5,285,126	$6,162,459
Segregated cash balances with brokers for foreign currency forward contracts	618,421	623,000
Unrealized appreciation on foreign currency forward contracts	2,312	308,424
Interest receivable	19,473	27,219
Total assets	5,925,332	7,121,102
Liabilities and shareholders’ equity
Liabilities
Payable to Sponsor	4,736	5,612
Unrealized depreciation on foreign currency forward contracts	169,440	1,475
Total liabilities	174,176	7,087
Commitments and Contingencies (Note 2)
Shareholders’ equity
Shareholders’ equity	5,751,156	7,114,015
Total liabilities and shareholders’ equity	$5,925,332	$7,121,102
Shares outstanding	550,000	600,000
Net asset value per share	$10.46	$11.86
Market value per share (Note 2)	$10.45	$11.84

Foreign Currency Forward Contract

	Settlement Date	Contract Amount in Local Currency	Contract Amount in U.S. Dollars	Unrealized Appreciation (Depreciation)/ Value
Contracts to Purchase
Euro with Goldman Sachs International	01/10/25	5,751,921	$5,960,572	$(85,224)
Euro with UBS AG	01/10/25	5,694,502	5,901,069	(84,216)
			Total Unrealized Depreciation	$(169,440)
Contracts to Sell
Euro with Goldman Sachs International	01/10/25	(58,000)	$(60,104)	$1,109
Euro with UBS AG	01/10/25	(287,000)	(297,410)	1,203
			Total Unrealized Appreciation	$2,312

^	The positions and counterparties herein are as of December 31, 2024. The Fund continually evaluates different counterparties for their transactions and counterparties are subject to change. New counterparties can be added at any time.

	Settlement Date	Contract Amount in Local Currency	Contract Amount in U.S. Dollars	Unrealized Appreciation (Depreciation)/ Value
Contracts to Purchase
Euro with Goldman Sachs International	01/19/24	6,949,921	$7,678,634	$164,104
Euro with UBS AG	01/19/24	6,107,502	6,747,886	144,320
			Total Unrealized Appreciation	$308,424
Contracts to Sell
Euro with Goldman Sachs International	01/19/24	(102,000)	$(112,695)	$(1,432)
Euro with UBS AG	01/19/24	(75,000)	(82,864)	(43)
			Total Unrealized Depreciation	$(1,475)

^	The positions and counterparties herein are as of December 31, 2023. The Fund continually evaluates different counterparties for their transactions and counterparties are subject to change. New counterparties can be added at any time.

	Year Ended December 31,
	2024	2023	2022
Investment Income
Interest	$270,617	$343,876	$149,251
Expenses
Management fee	56,629	77,062	100,481
Non-recurring fees and expenses	—	—	588
Total expenses	56,629	77,062	101,069
Net investment income (loss)	213,988	266,814	48,182
Realized and unrealized gain (loss) on investment activity
Net realized gain (loss) on
Foreign currency forward contracts	(576,761)	293,493	(953,353)
Short-term U.S. government and agency obligations	—	—	(5,949)
Net realized gain (loss)	(576,761)	293,493	(959,302)
Change in net unrealized appreciation (depreciation) on
Foreign currency forward contracts	(474,077)	(108,707)	333,004
Short-term U.S. government and agency obligations	—	—	452
Change in net unrealized appreciation (depreciation)	(474,077)	(108,707)	333,456
Net realized and unrealized gain (loss)	(1,050,838)	184,786	(625,846)
Net income (loss)	$(836,850)	$451,600	$(577,664)

	Year Ended December 31,
	2024	2023	2022
Shareholders’ equity, beginning of period	$7,114,015	$10,704,662	$8,659,095
Addition of 250,000, 300,000 and 1,550,000 shares, respectively	2,873,054	3,458,223	16,600,027
Redemption of 300,000, 650,000 and 1,250,000 shares, respectively	(3,399,063)	(7,500,470)	(13,976,796)
Net addition (redemption) of (50,000), (350,000) and 300,000 shares, respectively	(526,009)	(4,042,247)	2,623,231
Net investment income (loss)	213,988	266,814	48,182
Net realized gain (loss)	(576,761)	293,493	(959,302)
Change in net unrealized appreciation (depreciation)	(474,077)	(108,707)	333,456
Net income (loss)	(836,850)	451,600	(577,664)
Shareholders’ equity, end of period	$5,751,156	$7,114,015	$10,704,662

	Year Ended December 31,
	2024	2023	2022
Cash flow from operating activities
Net income (loss)	$(836,850)	$451,600	$(577,664)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Purchases of short-term U.S. government and agency obligations	—	—	(5,984,289)
Proceeds from sales or maturities of short-term U.S. government and agency obligations	—	—	6,988,249
Net amortization and accretion on short-term U.S. government and agency obligations	—	—	(11,779)
Net realized (gain) loss on investments	—	—	5,949
Change in unrealized (appreciation) depreciation on investments	474,077	108,707	(333,456)
Decrease (Increase) in interest receivable	7,746	13,202	(40,268)
Increase (Decrease) in payable to Sponsor	(876)	(5,221)	6,987
Net cash provided by (used in) operating activities	(355,903)	568,288	53,729
Cash flow from financing activities
Proceeds from addition of shares	2,873,054	3,458,223	16,600,027
Payment on shares redeemed	(3,399,063)	(7,500,470)	(13,976,796)
Net cash provided by (used in) financing activities	(526,009)	(4,042,247)	2,623,231
Net increase (decrease) in cash	(881,912)	(3,473,959)	2,676,960
Cash, beginning of period	6,785,459	10,259,418	7,582,458
Cash, end of period	$5,903,547	$6,785,459	$10,259,418

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.